14
PERGUNTAS & RESPOSTAS
RETINOPATIA DIABÉTICA - Novo Paradigma de Cuidados
18.
Klein R. The Diabetes Control and Complications Trial. In: Kertes C,
ed. Clínical Trials in Ophthalmology: A Summary and Practice Guide.
1998:49-70.
19.
Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR,
et al. Randomized trial evaluating ranibizumab plus prompt or deferred
laser or triamcinolone plus prompt laser for diabetic macular edema.
Ophthalmology. Jun 2010;117(6):1064-1077.e35.
20.
Rodriguez-Fontal M, Kerrison JB, Alfaro DV, Jablon EP. Metabolic control
and diabetic retinopathy. Curr Diabetes Rev. Feb 2009;5(1):3-7.
21.
Liew G, Mitchell P, Wong TY. Systemic management of diabetic retinopa-
thy. BMJ. Feb 12 2009;338:b441.
22.
Bhavsar AR. Diabetic retinopathy: the latest in current management. Reti-
na. Jul-Aug 2006;26(6 Suppl):S71-9.
23.
Bhavsar AR, Grillone LR, McNamara TR, Gow JA, Hochberg AM, Pear-
son RK. Predicting response of vitreous hemorrhage after intravitreous
injection of highly purified ovine hyaluronidase (Vitrase) in patients with
diabetes. Invest Ophthalmol Vis Sci. Oct 2008;49(10):4219-25.
24.
Arevalo JF, Garcia-Amaris RA. Intravitreal bevacizumab for diabetic reti-
nopathy. Curr Diabetes Rev. Feb 2009;5(1):39-46.
25.
Rodriguez-Fontal M, Alfaro V, Kerrison JB, Jablon EP. Ranibizumab for
diabetic retinopathy. Curr Diabetes Rev. Feb 2009;5(1):47-51.
26.
Diabetic Retinopathy Clínical Research Network. A randomized trial
comparing intravitreal triamcinolone acetonide and focal/grid pho-
tocoagulation for diabetic macular edema. Ophthalmology. Sep
2008;115(9):1447-9, 1449.
e1-10.
27.
Meredith TA. Clínical Trials in Ophthalmology-A Summary and Practice
Guide. In: Kertes C, ed. The diabetic vitrectomy study. 1998:37-48.
28.
Centers for Disease Control and Prevention; NationalCenter for Health
Statistics. National Health andNutrition Examination Surveys: response
rates & CPSpopulation totals.
http://www.cdc.gov/nchs/nhanes/respon
-
se_rates_CPS.htm. Accessed February 22,2010.
29.
Amostra ECOS 2010; Departamento de Epidemiologia Instituto Nacional
de Saúde Dr. Ricardo Jorge (INSA)
30.
Yanoff pag 620: klein R, Klein B, Moss S, et al. The Wisconsin epidemilo-
gic study of diabetic retinopathy. XIV. Ten-year incidence and progression
of diabetic retinopathy. Arch Ophthalmol.1994;112:1217-28
31.
Yanko L, Goldbourt U, Michaelson C, et al. Prevalence and 15-year inci-
dence of retinopathy and associated characteristics in middle-aged and
elderly diabetic men. Br J Ophthalmol.1983;67:759-65
32.
The Information Centre (2008). Health Survey for England 2006www.
ic.nhs.uk/webfiles/publications/HSE06/HSE%2006%20report%20
VOL%201%20v2
33.
Northam EA, Anderson PJ, Werther GA, et al. Neuropsychological com-
plications of IDDM in children 2 years after disease onset. Diabetes Care
1998; 21:379.
34.
Rovet J, Alvarez M. Attentional functioning in children and adolescents